Last updated: November 7, 2022
Sponsor: Peking University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mood Disorders
Kleptomania
Treatment
N/AClinical Study ID
NCT05606224
NCRC2021M01
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18-65;
- Diagnosis of emotional disorders, including anxiety disorders (e.g., panic disorder,social anxiety disorder, generalized anxiety disorder), and unipolar depressiondisorders;
- If taking medication, haven't changed for at least 4 weeks before intervention onset,and no change in medicine is expected;
- Voluntary participation in this study and sign an informed consent form.
Exclusion
Exclusion Criteria:
- No access to the internet;
- Inadequate proficiency in Chinese;
- Previous participation in mindfulness-based programs longer than 6 weeks, and/orcurrent practice of meditation more than once per week;
- A history of schizophrenia or schizoaffective disorder, current organic mentaldisorders, substance abuse disorder, and pervasive developmental disorders;
- Manifesting with any self-injury or suicidal risks.
Study Design
Total Participants: 200
Study Start date:
February 20, 2022
Estimated Completion Date:
August 30, 2023
Connect with a study center
Beijing Anding Hospital
Beijing, Beijing
ChinaActive - Recruiting
Beijing Tiantan Hospital
Beijing, Beijing
ChinaActive - Recruiting
Fosha Mental Health Center
Foshan, Guangdong
ChinaActive - Recruiting
Nanjing Brain Hospital
Nanjing, Jiangsu
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.